A framework of NGO inside and outside strategies in the commercial determinants of health: findings from a narrative review.

Advocacy Civil society Commercial determinants of health Health policy NGO Policy Public health

Journal

Globalization and health
ISSN: 1744-8603
Titre abrégé: Global Health
Pays: England
ID NLM: 101245734

Informations de publication

Date de publication:
10 10 2023
Historique:
received: 05 04 2023
accepted: 02 10 2023
medline: 12 10 2023
pubmed: 11 10 2023
entrez: 10 10 2023
Statut: epublish

Résumé

Public health scholarship has uncovered a wide range of strategies used by industry actors to promote their products and influence government regulation. Less is known about the strategies used by non-government organisations to attempt to influence commercial practices. This narrative review applies a political science typology to identify a suite of 'inside' and 'outside' strategies used by NGOs to attempt to influence the commercial determinants of health. We conducted a systematic search in Web of Science, ProQuest and Scopus. Articles were eligible for inclusion if they comprised an empirical study, explicitly sought to examine 'NGOs', were in English, and identified at least one NGO strategy aimed at commercial and/or government policy and practice. One hundred forty-four studies met the inclusion criteria. Eight industry sectors were identified: extractive, tobacco, food, alcohol, pharmaceuticals, weapons, textiles and asbestos, and a small number of general studies. We identified 18 types of NGO strategies, categorised according to the target (i.e. commercial actor or government actor) and type of interaction with the target (i.e. inside or outside). Of these, five NGO 'inside' strategies targeted commercial actors directly: 1) participation in partnerships and multistakeholder initiatives; 2) private meetings and roundtables; 3) engaging with company AGMs and shareholders; 4) collaborations other than partnerships; and 5) litigation. 'Outside' strategies targeting commercial actors through the mobilisation of public opinion included 1) monitoring and reporting; 2) protests at industry sites; 3) boycotts; 4) directly engaging the public; and 5) creative use of alternative spaces. Four NGO 'inside' strategies directly targeting government actors included: 1) lobbying; 2) drafting legislation, policies and standards; 3) providing technical support and training; and 4) litigation. NGO 'outside' strategies targeting government included 1) protests and public campaigns; 2) monitoring and reporting; 3) forum shifting; and 4) proposing and initiating alternative solutions. We identified three types of NGO impact: substantive, procedural, and normative. The analysis presents a matrix of NGO strategies used to target commercial and government actors across a range of industry sectors. This framework can be used to guide examination of which NGO strategies are effective and appropriate, and which conditions enable NGO influence.

Sections du résumé

BACKGROUND
Public health scholarship has uncovered a wide range of strategies used by industry actors to promote their products and influence government regulation. Less is known about the strategies used by non-government organisations to attempt to influence commercial practices. This narrative review applies a political science typology to identify a suite of 'inside' and 'outside' strategies used by NGOs to attempt to influence the commercial determinants of health.
METHODS
We conducted a systematic search in Web of Science, ProQuest and Scopus. Articles were eligible for inclusion if they comprised an empirical study, explicitly sought to examine 'NGOs', were in English, and identified at least one NGO strategy aimed at commercial and/or government policy and practice.
RESULTS
One hundred forty-four studies met the inclusion criteria. Eight industry sectors were identified: extractive, tobacco, food, alcohol, pharmaceuticals, weapons, textiles and asbestos, and a small number of general studies. We identified 18 types of NGO strategies, categorised according to the target (i.e. commercial actor or government actor) and type of interaction with the target (i.e. inside or outside). Of these, five NGO 'inside' strategies targeted commercial actors directly: 1) participation in partnerships and multistakeholder initiatives; 2) private meetings and roundtables; 3) engaging with company AGMs and shareholders; 4) collaborations other than partnerships; and 5) litigation. 'Outside' strategies targeting commercial actors through the mobilisation of public opinion included 1) monitoring and reporting; 2) protests at industry sites; 3) boycotts; 4) directly engaging the public; and 5) creative use of alternative spaces. Four NGO 'inside' strategies directly targeting government actors included: 1) lobbying; 2) drafting legislation, policies and standards; 3) providing technical support and training; and 4) litigation. NGO 'outside' strategies targeting government included 1) protests and public campaigns; 2) monitoring and reporting; 3) forum shifting; and 4) proposing and initiating alternative solutions. We identified three types of NGO impact: substantive, procedural, and normative.
CONCLUSION
The analysis presents a matrix of NGO strategies used to target commercial and government actors across a range of industry sectors. This framework can be used to guide examination of which NGO strategies are effective and appropriate, and which conditions enable NGO influence.

Identifiants

pubmed: 37817196
doi: 10.1186/s12992-023-00978-x
pii: 10.1186/s12992-023-00978-x
pmc: PMC10565967
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

74

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

Global Health. 2017 Jun 15;13(1):34
pubmed: 28619031
Lancet Glob Health. 2016 Dec;4(12):e895-e896
pubmed: 27855860
Tob Control. 2022 Jun;31(Suppl 1):s18-s25
pubmed: 35140171
Drug Alcohol Rev. 2006 Nov;25(6):625-32
pubmed: 17132578
Tob Control. 2020 Sep;29(5):548-555
pubmed: 31363061
Health Promot Int. 2020 Aug 1;35(4):877-887
pubmed: 31504470
Health Policy Plan. 2016 Apr;31 Suppl 1:i87-97
pubmed: 26276763
Health Policy Plan. 2016 Apr;31 Suppl 1:i74-86
pubmed: 26253698
J Public Health Policy. 2010 Apr;31(1):74-87
pubmed: 20200527
Afr J AIDS Res. 2017 Mar;16(1):57-64
pubmed: 28367744
Obes Rev. 2013 Nov;14 Suppl 2:69-78
pubmed: 24103026
BMC Public Health. 2018 Nov 28;18(1):1321
pubmed: 30486817
Int J Environ Res Public Health. 2017 Oct 31;14(11):
pubmed: 29088113
Addiction. 2014 May;109(5):711-9
pubmed: 24588798
BMJ Open. 2020 Nov 26;10(11):e044710
pubmed: 33243822
Int J Environ Res Public Health. 2013 Aug 06;10(8):3424-34
pubmed: 23924884
Health Policy Plan. 2018 Jun 1;33(5):633-644
pubmed: 29635414
Nutrients. 2017 Oct 17;9(10):
pubmed: 29039802
Global Health. 2020 Aug 17;16(1):74
pubmed: 32807183
Tob Control. 2017 Jul;26(4):464-467
pubmed: 27432913
Salud Publica Mex. 2010;52 Suppl 2:S330-9
pubmed: 21243206
Global Health. 2016 Jul 16;12(1):40
pubmed: 27424031
Global Health. 2018 Jul 25;14(1):73
pubmed: 30045738
Health Policy Plan. 2020 Oct 1;35(8):941-952
pubmed: 32672333
Int J Health Policy Manag. 2022 Dec 6;11(11):2489-2501
pubmed: 35065543
Public Health Nutr. 2019 Nov;22(16):3083-3091
pubmed: 31439059
Health Policy Plan. 2011 Sep;26(5):405-12
pubmed: 21051475
Lancet Glob Health. 2022 Jul;10(7):e1067-e1072
pubmed: 35623376
Health Promot Int. 2022 Feb 17;37(1):
pubmed: 33729472
Glob Health Action. 2021 Jan 1;14(1):1892307
pubmed: 33874854
Glob Public Health. 2012;7(1):14-28
pubmed: 21347934
Am J Public Health. 2017 Jul;107(7):1047-1049
pubmed: 28590869
J Urban Health. 2014 Feb;91(1):72-83
pubmed: 24129810
Aust N Z J Public Health. 2022 Aug;46(4):455-462
pubmed: 35616401
BMC Public Health. 2017 Jun 13;17(Suppl 2):492
pubmed: 28675131
Glob Public Health. 2009;4(2):150-68
pubmed: 19333806
Global Health. 2018 Feb 15;14(1):21
pubmed: 29448968
Global Health. 2021 Jan 5;17(1):5
pubmed: 33402166
Addiction. 2021 Sep;116(9):2577-2585
pubmed: 33464706
Health Info Libr J. 2009 Jun;26(2):91-108
pubmed: 19490148
Int J Health Policy Manag. 2017 Nov 11;7(2):101-111
pubmed: 29524934
Lancet. 2023 Apr 8;401(10383):1214-1228
pubmed: 36966783
Glob Public Health. 2018 Aug;13(8):1050-1064
pubmed: 28816610
Nutr Rev. 2022 Jan 10;80(2):200-214
pubmed: 34015107
Indian J Public Health. 2011 Jul-Sep;55(3):234-9
pubmed: 22089692
Addiction. 2016 Jan;111(1):18-32
pubmed: 26173765
Nicotine Tob Res. 2020 Dec 12;22(12):2203-2212
pubmed: 32309853
Glob Health Gov. 2010 Spring;3(2):
pubmed: 27274776
Tob Control. 1998 Winter;7(4):397-408
pubmed: 10093175
Health Policy Plan. 2022 Jan 13;37(1):22-32
pubmed: 34369574
BMJ Glob Health. 2021 Aug;6(8):
pubmed: 34426403
Lancet. 2013 Feb 23;381(9867):670-9
pubmed: 23410611
Health Policy Plan. 2021 Apr 21;36(3):322-331
pubmed: 33367775
Glob Public Health. 2019 Jun - Jul;14(6-7):1020-1030
pubmed: 29473460
Tob Control. 2018 Mar;27(2):185-194
pubmed: 28336521
Natl Med J India. 2013 Jul-Aug;26(4):227-30
pubmed: 24758450
Lancet. 2023 Apr 8;401(10383):1194-1213
pubmed: 36966782
Dev Pract. 2000 May;10(2):151-65
pubmed: 12295912
Nicotine Tob Res. 2020 Dec 12;22(12):2213-2223
pubmed: 31535694
Lancet. 2023 Apr 8;401(10383):1229-1240
pubmed: 36966784
Health Educ Behav. 2005 Jun;32(3):298-319; discussion 355-62
pubmed: 15851541
PLoS Med. 2012;9(6):e1001235
pubmed: 22745605

Auteurs

Belinda Townsend (B)

Australian Research Centre for Health Equity, School of Regulation and Global Governance, Australian National University, Canberra, Australia. belinda.townsend@anu.edu.au.

Timothy D Johnson (TD)

Australian Research Centre for Health Equity, School of Regulation and Global Governance, Australian National University, Canberra, Australia.

Rob Ralston (R)

Global Health Policy Unit, Social Policy, School of Social and Political Science, University of Edinburgh, Edinburgh, UK.

Katherine Cullerton (K)

School of Public Health, University of Queensland, Herston, Australia.

Jane Martin (J)

Obesity Policy Coalition, Melbourne, Australia.

Jeff Collin (J)

Global Health Policy Unit, Social Policy, School of Social and Political Science, University of Edinburgh, Edinburgh, UK.

Fran Baum (F)

Stretton Health Equity & School of Social Science, University of Adelaide, Adelaide, Australia.

Liz Arnanz (L)

NCD Alliance, Geneva, Switzerland.

Rodney Holmes (R)

Foundation for Alcohol Research and Education, Canberra, Australia.

Sharon Friel (S)

Australian Research Centre for Health Equity, School of Regulation and Global Governance, Australian National University, Canberra, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH